19 Jul 2023Open access10cites
<scp>CSRP2</scp> promotes cell stemness in head and neck squamous cell carcinomaPublisher siteHead & Neck, Peptidase Inhibition and Analysis
Active, last published 2026
In nanoplatforms for cancer theranostics
Shu‐Cheng
Wan
Scholar“Research focused on Nanoplatforms for cancer theranostics and adjacent fields.”
Université de Kinshasa (UNIKIN)
DR Congo
Claim Your ProfileDR Congo15
H-index
1.1k
Citations
Shu‐Cheng has not officially claimed their profile. If you are Shu‐Cheng, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
hu‐Cheng Wan is a researcher working on Nanoplatforms for cancer theranostics. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Shu‐Cheng's work has been cited 1,077 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Nanoplatforms for cancer theranostics×13Peptidase Inhibition and Analysis×8Cancer Immunotherapy and Biomarkers×7Inflammasome and immune disorders×5Advanced Nanomaterials in Catalysis×5
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Kinshasa, DR CongoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works22 Nov 2022Open access
CSRP2 Influences cell Stemness and Prognosis in Head and Neck CancerPublisher siteResearch Square, Peptidase Inhibition and Analysis
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Shu‐Cheng?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you